维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="Bisagni G"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer: A prospective randomized study显示文摘	Colozza M Bisagni G Mosconi A	2002	Eur J Cancer2002，38，：	1
	2	The Breast Avastin Trial:phase Ⅱ study of bevacizumab maintenance therapy afier induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer 显示文摘	BISAGNI G MUSOLINO A PANEBIANCO M	2013	Cancer Chemother Pharmacol2013，71，：	1
	3	Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma:a randomized phase Ⅱ trial显示文摘	Cocconi G Bisagni G Ceci G	1999	Breast Cancer Res Treat1999，56，：	1
	4	Epirubicin versus CMF as adjuvant therapy for stage I and II breast cancer:A prospective randomized study显示文摘	Colozza M Bisagni G Mosconi A	2012	Eur J Cancer2012，38，17：	1
	5	Progressive crushing of fiber-reinforced composite structural components of a Formula One racing car 显示文摘	Bisagni C Di Pietro G Fraschini L	2005	Composite Structures2005，68，4：	1
	6	The Breast Avastin Trial:phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer显示文摘	Bisagni G Musolino A Panebianco M	2013	Cancer Chemoth Pharm2013，71，4：	1
	7	The breast avastin trial:phaseⅡstudy of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer显示文摘	Bisagni G Musolino A Panebianco M	2013	Cancer Chemother Pharmacol2013，71，4：	1
	8	Lonidamine in advanced colorectal cancer:a phase Ⅱ study of the Italian Oncology Group for Clinical Research(GOIRC)显示文摘	Passalacqua R Bisagni G Bertusi M	1989	Tumori1989，75，3：	1
	9	The Breast Avastin Trial:phase Ⅱ study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer显示文摘	Bisagni G Musolino A Panebianco M		0，，04：	1
	10	The Breast Avastin Trial: phase II study of bevaeizumab maintenance therapy after induction chemotherapy with doeetaxel and eapeeitabine for the first-line treatment of patients with locally recurrent or metastaticbreast cancer显示文摘	Bisagni G Musolino A Panebianeo M	2013	Cancer Chemother Pharmacol2013，71，4：	1
	11	Low-dose aminoglutethimide with and without hydrocorfisone replacement as a first-line endocrine treatment in advanced brdast cancer: A prospective randomized trial of the Italian Oncology Group FOR clinical Research显示文摘	Bisagni G Ceci G	1992	J Clin Oncol1992，10，：	1
	12	Long lasting response to the multikinase inhibitor bay43-9006 (sorafenib) in a heavily pretrea- ted metastatic thymic carcinoma 显示文摘	Bisagni G Rossi G Cavazza A	2009	J Thorac Oncol2009，4，6：	1
	13	Long lasting response to the multikinase inhibitor bay 43-9006(Sorafenib) in a heavily pretreated metastatic thymic carcinoma显示文摘	Bisagni G Rossi G Cavazza A	2009	J Thorac Oncol2009，4，6：	1
	14	Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma 显示文摘	Bisagni G Rossi G Cavazza A	2009	J Thorac Oncol2009，4，6：	1
	15	Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretrea- ted metastatic thymic carcinoma 显示文摘	Bisagni G Rossi G Cavazza A	2009	J Thorac Oncol2009，4，6：	1
	16	Combination thera- py with platinum and etoposide of brain metastases from breast carcinoma显示文摘	Cocconi G Lottici R Bisagni G	1990	Cancer Invest1990，8，34：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费